Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026)
Bausch Health Companies (BHC) posted Amortization - Intangibles of $225.0 million for Q2 2026, down 6.64% sequentially from $241.0 million in Q1 2026, and down 12.11% YoY from $256.0 million in Q2 2025.
Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Amortization - Intangibles for 18 years, with the latest figure at $225.0 million in Q2 2026.
- Quarterly Amortization - Intangibles fell 12.11% year-over-year to $225.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $955.0 million (down 8.61% YoY) and the FY2025 annual result came in at $1.0 billion, down 7.06% from the prior year.
- Amortization - Intangibles slipped to $225.0 million in Q2 2026 per BHC's latest filing, from $241.0 million in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $313.0 million in Q4 2022 and troughed at $225.0 million in Q2 2026.
- A 5-year average of $268.7 million and a median of $269.5 million in 2023 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2022 and 2024: Amortization - Intangibles dropped 16.11% in 2022, then advanced 8.3% in 2024.
- Over 5 years, Amortization - Intangibles stood at $313.0 million in 2022, then declined by 9.9% to $282.0 million in 2023, then declined by 8.16% to $259.0 million in 2024, then declined by 8.88% to $236.0 million in 2025, then dropped by 4.66% to $225.0 million in 2026.
- According to Business Quant data, Amortization - Intangibles over the past three periods registered $225.0 million, $241.0 million, and $236.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Bausch Health Companies | 2.58 Bn | 738.25 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 225.00 Mn |
| Mar 31, 2026 | 241.00 Mn |
| Dec 31, 2025 | 236.00 Mn |
| Sep 30, 2025 | 253.00 Mn |
| Jun 30, 2025 | 256.00 Mn |
| Mar 31, 2025 | 256.00 Mn |
| Dec 31, 2024 | 259.00 Mn |
| Sep 30, 2024 | 274.00 Mn |
| Jun 30, 2024 | 270.00 Mn |
| Mar 31, 2024 | 274.00 Mn |
| Dec 31, 2023 | 282.00 Mn |
| Sep 30, 2023 | 253.00 Mn |
| Jun 30, 2023 | 269.00 Mn |
| Mar 31, 2023 | 273.00 Mn |
| Dec 31, 2022 | 313.00 Mn |
| Sep 30, 2022 | 290.00 Mn |
| Jun 30, 2022 | 302.00 Mn |
| Mar 31, 2022 | 310.00 Mn |
| Dec 31, 2021 | 320.00 Mn |
| Sep 30, 2021 | 338.00 Mn |